The molecular subgroup demographic analysis for the Combined glioblastoma cohort found a significantly higher patient age for the G7/Other and G6/Multi-RTK subgroups versus the G1/EGFR subgroup (Table 2 and Figure 2e). Here, EGFR is linked to glioblastoma.